Online prediction market Kalshi hit a daily record on Super Bowl Sunday, surpassing $1bn in trading volume, the company announced on Tuesday. Kalshi’s CEO, Tarek Mansour, called it an “incredible weekend”, telling CNBC that “Kalshi was the biggest brand of the Super Bowl this year, without running a Super Bowl ad”. Kalshi trading volume during the game was up 2,700% year over year. More than $100m...
Online prediction market Kalshi hit a daily record on Super Bowl Sunday, surpassing $1bn in trading volume, the company announced on Tuesday. Kalshi’s CEO, Tarek Mansour, called it an “incredible weekend”, telling CNBC that “Kalshi was the biggest brand of the Super Bowl this year, without running a Super Bowl ad”. Kalshi trading volume during the game was up 2,700% year over year. More than $100m were bets on Bad Bunny’s opening song and $45m on which artists would perform with him on stage. In comparison, the platform saw $27m in total trading volume at last year’s Super Bowl. Prediction markets like Kalshi allow users to trade on the outcomes of virtually anything, from sports and elections to what color someone will wear during a performance. Unlike casinos or traditional sportsbooks, users effectively bet (or “trade”) against others on the platform, instead of an established “house”, and the platforms earn revenue by charging trading fees. Kalshi and competitor Polymarket argue that this model distinguishes them from traditional casinos or sportsbooks. Since the US supreme court overturned the federal ban on sports betting in 2018, state gambling agencies regulate traditional gambling outfits, but prediction markets are currently overseen by the Commodity Futures Trading Commission. “The reason people are flocking to prediction markets, especially Kalshi, is that our incentive as a company [is] we win when the customers win, we don’t win when the customers lose, and that’s a huge difference in the model,” Mansour said on Tuesday. On Sunday, Kalshi told users that although some deposits were “delayed because of the amount of traffic and deposits we’re getting”, their money “is safe and on the way, it will just take longer to land”. Prediction markets have risen in popularity in recent months and are now used beyond sports, edging into other events such as the Grammys and Oscars. Last week, Kalshi announced that the NBA star Giannis Antetokounmpo was joining the ...
Black_Kira/iStock via Getty Images Overview Since my Sell rating in April 2025, SoundHound AI, Inc.'s ( SOUN ) stock is up 14% versus S&P 500 Index ( SPY ) gains of 34%. My caution on SoundHound stems from two key dealbreakers for me. Its growth has been driven by M&A, and its R&D spend pales in comparison to its competitors—leaving it challenging to envision the company succeeding long-term. Amid...
Black_Kira/iStock via Getty Images Overview Since my Sell rating in April 2025, SoundHound AI, Inc.'s ( SOUN ) stock is up 14% versus S&P 500 Index ( SPY ) gains of 34%. My caution on SoundHound stems from two key dealbreakers for me. Its growth has been driven by M&A, and its R&D spend pales in comparison to its competitors—leaving it challenging to envision the company succeeding long-term. Amidst all of this is its premium valuation . My April discounted cash flow analysis revealed that SOUN was overvalued by 12% based on assumptions of 50% CAGR and 25% free cash flow margins, on average, over a nine-year projection period—which is an arduous task for even a comfortably profitable top-tier company. For those unaware, SoundHound is primarily involved in voice AI agents—dealing in restaurants, auto, retail, and finance. Think of going through a drive-thru and having your order taken by some AI agent. That could be SoundHound’s technology! When I last covered SoundHound, they were growing revenues 85% year-over-year, achieving $84.7 million in 2024. It guided for $157 million-$177 million in 2025. The company was not yet profitable—burning (cash from operating activities) $33.1 million in Q4 2024. The article that follows reevaluates SOUN in light of its 2025 performance and ahead of its next earnings release on February 27th. Recent Trends One thing that merits a mention is that SoundHound’s stock has been victim to a broader software-associated ( IGV ) selloff—with its stock price being cut from >$20 in October 2025 to just $8.56 today. Seeking Alpha The company has not yet provided full-year 2025 figures (its Q4 earnings announcement date is set for 2/27), so I’m going to focus on its Q3 results . Q3 revenue was $42 million (up 68% year-over-year), and the company guided full-year 2025 revenue to fall between $165 million and $180 million. So this is a slight raise over its original full-year 2025 guidance. In the meantime, its profitability doesn't appear to hav...
What would Wallace - everyone’s favourite amateur Yorkshire inventor – look like with a moustache, straw boater and postman’s coat? Would a huge set of teeth suit his faithful beagle, Gromit? How about a nose shaped like a banana? Such questions are answered by an illuminating and sometimes alarming exhibition at east London’s Young V&A that showcases the work of the world’s leading stop-motion ou...
What would Wallace - everyone’s favourite amateur Yorkshire inventor – look like with a moustache, straw boater and postman’s coat? Would a huge set of teeth suit his faithful beagle, Gromit? How about a nose shaped like a banana? Such questions are answered by an illuminating and sometimes alarming exhibition at east London’s Young V&A that showcases the work of the world’s leading stop-motion outfit, the Bristol-based Aardman studios. Early sketches for Nick Park’s much-loved characters reveal that Wallace was once just a few bristles short of Hitler, while Gromit had fangs and the ability to speak. Such designs were judiciously smoothed along the way, with Gromit becoming toothless and mute, and Wallace’s long, thin face massaged into something wider and friendlier after Park watched Peter Sallis, the original voice of Wallace, enunciating the word “cheese”. Inside Aardman: Wallace & Gromit and Friends opens on Thursday and runs until 25 November, two months after the release of the studio’s third Shaun the Sheep movie, The Beast of Mossy Bottom. Aardman, which celebrates its 50th anniversary this year, is one of UK film’s most enduring and endearing success stories, with a current total of four Oscars and eight Baftas. Its first film, Chicken Run, is still the highest-grossing stop-motion movie of all time, taking $225m – about five times its budget – while its latest, Wallace & Gromit: Vengeance Most Fowl, became the BBC’s most-watched scripted show in two decades after it aired on Christmas Day in 2024. Sales for the exhibition are comparable to those enjoyed at the V&A’s main site in South Kensington. More than a quarter of the tickets have already gone, and the first three weeks are entirely sold out. More than 150 items are on display, including never-before-seen models, sets and storyboards from Aardman’s archives. They are all the more precious for their scarcity. A fire destroyed thousands of items in 2005, including the original Creature Comforts and Ch...
Key Points Oklo has impressive technology and some great contracts going for it. It's not a buy for 2026 and might be a sell as it has tumbled from its highs in 2025 and generates no revenue. The company has plenty of competition in the SMR industry, most of which are in a better spot financially. 10 stocks we like better than Oklo › Oklo (NYSE: OKLO) is an intriguing stock. It sits at the crossro...
Key Points Oklo has impressive technology and some great contracts going for it. It's not a buy for 2026 and might be a sell as it has tumbled from its highs in 2025 and generates no revenue. The company has plenty of competition in the SMR industry, most of which are in a better spot financially. 10 stocks we like better than Oklo › Oklo (NYSE: OKLO) is an intriguing stock. It sits at the crossroads of several big trends in nuclear power and tech, namely small modular reactors (SMRs) and their potential to solve the power problems created by artificial intelligence (AI). Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » It's also working on liquid-metal reactors, which use molten lead or sodium as a coolant. Note, Oklo's specifically are sodium-based. That sounds counterintuitive but in some ways it's actually safer than water because they can handle higher temperatures at lower pressure than conventional water-cooled reactors. Though, they aren't with their problems. Liquid sodium is much more corrosive than water, for instance. Finally, the company is working on an up to $1.68 billion nuclear fuel plant in Oak Ridge Tennessee. It has also partnered with the Air Force to put one of its Aurora small liquid-cooled reactors at the Eielson Air Force Base in Alaska. Despite all of that though, Oklo is not a buy for 2026, and given that it has tumbled considerably from its peak of $174 late last year, it might be a sell. Let's get into it. Potential energy, flawed reaction The problem with Oklo isn't its technology, it's the company's financials -- or rather the total lack thereof. Right now, Oklo generates no revenue whatsoever and is entirely dependent upon investor dollars and lines of credit. A lack of profitability can easily be forgiven if a company is growing its revenue regularly and getting clo...
Anne Czichos/iStock Editorial via Getty Images In looking back at bank stocks I covered over the last few years, one particular bullish call on Germany's Deutsche Bank Aktiengesellschaft ( DB ) stuck out, and so today I'm following up on that stock. During my early days on Seeking Alpha, I called this stock a strong buy in my June 2023 article , and since then it is up +255% as of this writing, an...
Anne Czichos/iStock Editorial via Getty Images In looking back at bank stocks I covered over the last few years, one particular bullish call on Germany's Deutsche Bank Aktiengesellschaft ( DB ) stuck out, and so today I'm following up on that stock. During my early days on Seeking Alpha, I called this stock a strong buy in my June 2023 article , and since then it is up +255% as of this writing, and since my bullish follow-up in Oct 2023, it is up around +251% since then too. So, this stock is among my best calls, and in both cases I thought it could be a good addition to a portfolio looking for exposure to large European banks that also trade shares directly on the NYSE, but I also thought its capital position was strong while the stock appeared undervalued to me at the time. Although I later recommended selling in my April 2025 coverage , expecting it to have reached its peak, it seems the market was much more confident than I was, driving the price up even further. So, with 2 of my 3 calls on this stock proving correct, this time I will approach it from a few additional angles and updated data to see if my prior thesis holds or changes. Nevertheless, this bank, which focuses on corporate and investment banking, private clients, and asset management products, recently had an earnings result on Jan 29th, so it is due for an update. Thesis Summary In my updated coverage of this stock, I am actually upgrading it back to a buy, agreeing with the overwhelming bullish consensus as of Monday. The worksheet below summarizes the factors that drove this score. DB - rating worksheet (author) Today's follow-up thesis argues that despite some lower upside forecasts and lack of clear technical buy signals, key strengths moving the needle towards the buy range include several positive macro forecasts and outlooks about this sector, as well as proven company growth in loans and net asset inflows, which can drive future interest and fee income. The credit rating remains stellar, al...
The first of several jury trials alleging that social media networks built products to get kids addicted kicked off in Los Angeles. Eric Goldman, professor at Santa Clara University School of Law, discusses the legal questions at the center of these cases with Caroline Hyde and Ed Ludlow on “Bloomberg Tech.” (Source: Bloomberg)
The first of several jury trials alleging that social media networks built products to get kids addicted kicked off in Los Angeles. Eric Goldman, professor at Santa Clara University School of Law, discusses the legal questions at the center of these cases with Caroline Hyde and Ed Ludlow on “Bloomberg Tech.” (Source: Bloomberg)
Federal Reserve Bank of Cleveland President Beth Hammack says interest rates could be on an extended hold while officials evaluate incoming economic data during an event in Columbus, Ohio. (Source: Bloomberg)
Federal Reserve Bank of Cleveland President Beth Hammack says interest rates could be on an extended hold while officials evaluate incoming economic data during an event in Columbus, Ohio. (Source: Bloomberg)
Paramount Skydance says it would pay a $2.8 billion termination fee Warner would have to pay if it breaks off the deal with Netflix. Lucas Shaw reports. (Source: Bloomberg)
Paramount Skydance says it would pay a $2.8 billion termination fee Warner would have to pay if it breaks off the deal with Netflix. Lucas Shaw reports. (Source: Bloomberg)
Susumu Yoshioka/DigitalVision via Getty Images The WisdomTree Japan SmallCap Dividend Fund ETF ( DFJ ) is an ETF that we've covered in the past . The themes were that there was less export indexation here than in larger-cap, more passive ETFs for the Japanese market, like the ( EWJ ), which has a lower expense ratio at 0.49% compared to the 0.58% of the DFJ. FX continues to be an important conside...
Susumu Yoshioka/DigitalVision via Getty Images The WisdomTree Japan SmallCap Dividend Fund ETF ( DFJ ) is an ETF that we've covered in the past . The themes were that there was less export indexation here than in larger-cap, more passive ETFs for the Japanese market, like the ( EWJ ), which has a lower expense ratio at 0.49% compared to the 0.58% of the DFJ. FX continues to be an important consideration for approaching the Japanese market. To have made good money in these markets lately without an FX hedge, you have to be positioned such that a decline in the JPY, which is becoming more and more marginal as new and less conservative fiscal leadership takes the reins of Japan, actually works fundamentally for the portfolio. Smaller-cap stocks in Japan will typically be more domestically exposed and therefore are more at risk of the FX declines. On the other hand, a more fiscally expansive policy expected from the Takaichi administration should also help drive some expansion in domestic markets on the demand side as well. Also for financial exposures, indeed a concern also for the value-weighted large-cap inde x, there is a bit of a doom-loop between the Japanese fiscal position, demand for bonds, balance sheet exposure, and related risk to the currency. The issue for small caps is that we worry there might be more downside for the FX than upside for a market with consumers that have a high propensity to save incremental disposable income. DFJ Breakdown Sectors (WisdomTree) Sectoral exposures are as above. While there is usually some foreign exposure in any given industrial, materials, or consumer discretionary exposure, there is much more domestic demand than there would be for a lot of the large-cap index, which is dominated by leading export brands with revenue mostly coming from abroad. Therefore, there is more exposure to FX. While end customers might be more indexed to export markets, as ultimately the bulk of the Japanese economy is export-led, relative strengt...
Investors obsessed with efficiency — a thinly veiled euphemism for layoffs — may have found an unlikely ally in Superhuman CEO Shishir Mehrotra. "I don't view [AI] as a job taker. I view it as a job expander," Mehrotra told Yahoo Finance. "In my mind, we're about to give everybody 100 new employees." He added that the likely result is the workforce is taught to use management skills to oversee dig...
Investors obsessed with efficiency — a thinly veiled euphemism for layoffs — may have found an unlikely ally in Superhuman CEO Shishir Mehrotra. "I don't view [AI] as a job taker. I view it as a job expander," Mehrotra told Yahoo Finance. "In my mind, we're about to give everybody 100 new employees." He added that the likely result is the workforce is taught to use management skills to oversee digital teams. It is a bold, and perhaps overly optimistic, rebrand of the AI revolution. But it is one that Mehrotra is betting his entire company on — quite literally. In mid-2025, the writing-assistant giant Grammarly acquired the premium email app Superhuman and then, in a surprising twist, rebranded the entire $13 billion conglomerate under the Superhuman name. The logic behind the merger was clear. At the time, Grammarly had over 40 million daily users, but Superhuman email client provided the "surface" where professionals spent the bulk of their day. By combining Superhuman's email app, Grammarly's writing intelligence, and Coda's collaborative workspace (another 2025 acquisition), the new Superhuman aims to be the AI-native productivity suite that challenges the dominance of Microsoft (MSFT) and Google (GOOG, GOOGL). The "100 agents" Mehrotra describes aren't just fancy chatbots. He visualizes them as digital assistants, designed to pull data from CRMs, summarize support tickets, and draft replies in a user's specific voice. Lisbon , Portugal - 11 November 2025; Shishir Mehrotra, CEO, Superhuman (formerly Grammarly),on Centre stage during day one of Web Summit 2025 at the MEO Arena in Lisbon, Portugal. (Photo By Alex Broadway/Sportsfile for Web Summit via Getty Images) · Alex Broadway via Getty Images In his view, the metric for success isn't just about how many people use OpenAI's (OPAI.PVT) ChatGPT, it's about the volume of background work being done. Grammarly users, he notes, are already triggering over 100 billion LLM calls a week. However, investors should remain...
J.P. Morgan says fears of an AI-driven software wipeout are overblown and highlights 19 stocks—from Microsoft to CrowdStrike—it believes are positioned to rebound.
J.P. Morgan says fears of an AI-driven software wipeout are overblown and highlights 19 stocks—from Microsoft to CrowdStrike—it believes are positioned to rebound.
(RTTNews) - Swiss stocks swung between gains and losses in cautious trading on Tuesday as investors appeared reluctant to make significant moves, choosing to wait for some clear direction. The benchmark SMI, which moved in a tight band of about 65 points, settled at 13,518.22, little changed from previous close of 13,517.73. Richemont climbed 2.25%. Givaudan gained about 1.85%, while Alcon and Geb...
(RTTNews) - Swiss stocks swung between gains and losses in cautious trading on Tuesday as investors appeared reluctant to make significant moves, choosing to wait for some clear direction. The benchmark SMI, which moved in a tight band of about 65 points, settled at 13,518.22, little changed from previous close of 13,517.73. Richemont climbed 2.25%. Givaudan gained about 1.85%, while Alcon and Geberit closed higher by about 1.55% at CHF61.02 and CHF633.80, respectively. Lindt & Spruengli, Sika, Straumann Holding, Partners Group, Schindler Ps, Logitech International, Nestle and Novartis also closed on firm note. Zurich Insurance Group closed down by 3.16%, and Julius Baer ended 3.04% down. UBS Group, Kuehne + Nagel, Helvetia Baloise Holding, Sandoz Group, Holcim and Amrize lost 1%-1.5%. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The question on many investors' minds is whether Nvidia (NASDAQ: NVDA), one of the best-performing stocks in the market, is still a buy after its huge run-up the past five years. For those who missed out on buying the stock, let's look at five reasons that I think the answer is still yes. 1. The AI arms race Currently there is a race among big technology companies to build data centers designed to...
The question on many investors' minds is whether Nvidia (NASDAQ: NVDA), one of the best-performing stocks in the market, is still a buy after its huge run-up the past five years. For those who missed out on buying the stock, let's look at five reasons that I think the answer is still yes. 1. The AI arms race Currently there is a race among big technology companies to build data centers designed to handle artificial intelligence (AI). This is a handful of some of the biggest names in tech. While investors might not always be fans of their spending plans, capital expenditure (capex) budgets for these tech leaders are on the rise. The big names that are spending on AI infrastructure include cloud computing stalwarts Microsoft, Amazon, Alphabet, and companies like Meta Platforms, Oracle, OpenAI, and Elon Musk's Tesla and xAI. Both Alphabet and Meta Platforms have come out and said that the biggest risk with their AI infrastructure build-outs is underinvesting, given the huge opportunity AI presents. Musk, meanwhile, built his own data center for xAI because Oracle couldn't produce the AI cluster it needed fast enough. And while these large tech companies duke it out, the one company best positioned to continue to reap the rewards is Nvidia, which through the sale of its graphics processing units (GPUs) is essentially the arms dealer in the battle for AI supremacy. 2. Exponential computing power will be needed As these companies build their AI infrastructure, there is no sign that this spending will let up. The big reason is that as large language models (LLMs) advance, they need more computing power to be trained on. And they won't need a few more GPUs for training -- they will need exponentially more. For example, xAI's Grok 2 model used 20,000 GPUs to train, while its Grok 3 model will use 100,000. Meta Platforms has said its next-generation Llama 4 model will likely need 10 times the computing power as Llama 3. That would bring the number of GPUs required to train th...
Key Points The growth potential in the GLP-1 market could help healthcare stocks soar in value. Competition, however, is likely to be fierce. Many drugs offer comparable weight loss. 10 stocks we like better than Eli Lilly › Healthcare companies have been feverishly working on developing GLP-1 weight loss products in an effort to cash in on what's turning out to be a massive gold rush in the secto...
Key Points The growth potential in the GLP-1 market could help healthcare stocks soar in value. Competition, however, is likely to be fierce. Many drugs offer comparable weight loss. 10 stocks we like better than Eli Lilly › Healthcare companies have been feverishly working on developing GLP-1 weight loss products in an effort to cash in on what's turning out to be a massive gold rush in the sector. Companies big and small have GLP-1 drug candidates in development that, if successful, could be game changers for their businesses. It could put small stocks on the map, and for larger companies, it could mean an improvement in their growth rates. It may seem exciting to invest in GLP-1 stocks for their future growth potential, but there are important things to consider before you dive in. Here are three key things you should know about GLP-1 stocks, to help you decide whether it can be a good area for you to invest in. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » The market is massive, but estimates have been coming down Given the potential for weight loss drugs to improve the overall health of patients and their wide-ranging benefits, analysts have been understandably bullish on the space. But perhaps they have been too excited about it. Goldman Sachs recently trimmed its forecast for the anti-obesity drug market. It projects that theglobal marketwill be worth $95 billion by the end of the decade, which is a sizable decrease from the $130 billion it was previously forecasting. It's still massive, but it's a sign of just how much hype there has been around GLP-1 drugs. And with concerns about side effects and people gaining weight back after they stop using the drugs, it's possible there may still be too much hype right now. Competition is likely to ramp up Today, Eli Lilly (NYSE: LLY) looks to be the early leader in the GLP-1 space, as it has bee...